Subscribe To
Morphic to present positive emerald-1 phase 2a data for morf-057 in patients with moderate to severe ulcerative colitis in abstract for uegw 2023
-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures-...
September 22, 2023, 9:30 pm
Aldeyra:upcoming pdufa, strong nda, long pipeline, decent cash
Aldeyra is a late-stage company developing therapies for immune-mediated diseases, with a focus on dry eye disease and allergic conjunctivitis. Their ...
September 22, 2023, 7:44 pm
Morphic to present positive emerald-1 phase 2a data for morf-057 in patients with moderate to severe ulcerative colitis in abstract for uegw 2023
-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures-...
September 22, 2023, 5:30 pm
Protagonist therapeutics: there are reasons behind johnson & johnson's optimism
Protagonist Therapeutics, Inc.'s oral IL-23 drug for psoriasis, JNJ-2113, must show non-inferior efficacy to Johnson & Johnson's injectable Tremfya be...
September 22, 2023, 3:35 pm
Jazz pharma (jazz) gets eu nod for cancer drug enrylaze
The approval is based on data from a phase II/III study, which showed that treatment with Jazz's (JAZZ)...
September 22, 2023, 1:31 pm
Seagen-merck bladder cancer treatment shows positive results; seagen shares jump
Biotechnology company Seagen Inc. (SGEN) and Tokyo-based Astellas Pharma Inc. on Friday reported positive results from a ...
September 22, 2023, 12:40 pm
Astrazeneca adss rise after reporting positive results in breast cancer drug trial
AstraZeneca (AZN) ADSs rose after reporting its experimental breast cancer treatment made with Japanese partner Daiichi Sankyo showed positive high-le...
September 22, 2023, 12:10 pm
Enphase (enph) unveils new products for the uk solar market
Enphase (ENPH) recently unveiled a new home energy system for the United Kingdom's solar market, powere...
September 22, 2023, 10:31 am
Moleculin (mbrx) posts update from lung cancer study, stock up
Moleculin (MBRX) completes enrollment in the phase II portion of the development program for its lead c...
September 22, 2023, 9:01 am
Usd/jpy seems to have now moved into a consolidative phase – uob
USD/JPY now seems to face a 146.50-148.50 range in the short-term horizon, comment UOB Group’s Economist Lee Sue Ann and Markets Strategist Quek Ser...
September 22, 2023, 7:59 am
Better buy: this top-shelf renewable energy etf or a 50/50 split of enphase and solaredge?
After a rip-roaring year in 2020, the solar industry has undergone a brutal sell-off. The Invesco Solar ETF offers a sizeable amount of international ...
September 22, 2023, 5:44 am
Relmada (rlmd) up on positive data for anti-depressant candidate
Relmada's (RLMD) shares rise on long-term efficiency and safety data from the phase III study of its le...
September 21, 2023, 3:02 pm
Why shares of calliditas therapeutics are rising thursday
Calliditas' lead therapy is Tarpeyo, which has accelerated approval from the FDA to fight a rare autoimmune disease affecting the kidney. The company ...
September 21, 2023, 2:32 pm
Prothena: switching from 'hold' to 'buy' on lead alzheimer's drug promise
Prothena Corporation is a protein dysregulation specialist with a focus on developing drugs for Alzheimer's disease. The company's lead candidate, PRX...
September 21, 2023, 1:39 pm
Why shares of travere therapeutics are slumping thursday
Travere said that Filspari was promising in preserving kidney function. The therapy did not meet all of its endpoints in a ...
September 21, 2023, 12:57 pm
Nvidia: correction phase is not over
Nvidia Corporation's strong quarterly results did not lead to a bullish rally in the stock, as most of the future growth has already been priced in. B...
September 21, 2023, 12:48 pm
Why is seelos therapeutics (seel) stock down 25% today?
Seelos Therapeutics (NASDAQ: SEEL ) stock is falling on Thursday after the company released results from a clinical trial. Seelos Therapeutics first ...
September 21, 2023, 9:30 am
Enphase stock is a buy ahead of a solar recovery, analyst says
Seaport analyst Tom Curran upgraded shares of solar-tech firm Enphase to Buy from Neutral, and set a $1...
September 21, 2023, 8:37 am
Jasper therapeutics to present new positive data on briquilimab conditioning in patients with fanconi anemia at the 2023 fanconi anemia research fund scientific symposium
REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
September 21, 2023, 8:00 am
Usdcad analysis – september 21, 2023
USDCAD has broken above the falling trend line on the 4-hour chart, indicating a potential shift in the market sentiment. This breakout suggests that ...
September 21, 2023, 1:23 am